Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016

BACKGROUND: New hepatitis C virus (HCV) drugs—direct-acting antivirals (DAAs)—are highly effective but costly, which raises a concern about limited access to DAAs by vulnerable populations. Previous studies of disparities in DAA use across patient groups showed mixed results, but their generalizabil...

Full description

Saved in:
Bibliographic Details
Published in:J Manag Care Spec Pharm
Main Authors: Jung, Jeah, Du, Ping, Feldman, Roger, Kong, Lan, Riley, Thomas
Format: Artigo
Language:Inglês
Published: Academy of Managed Care Pharmacy 2019
Subjects:
Research Brief
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6823635/
https://ncbi.nlm.nih.gov/pubmed/31663464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18553/jmcp.2019.25.11.1236
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items